American Association of Neurological Surgeons (AANS). Neurosurgical conditions and treatments: Spasticity. Available at: https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Spasticity. Accessed on January 26, 2023.
American Cancer Society (ACS). Chapter 20-Colon and Rectum. [ACS Web site]. Revised: 06/29/2020. Available at: https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/staged.html. Accessed January 26, 2023.
American Cancer Society. Chemotherapy for liver cancer. [ACS Web site]. Available at: https://www.cancer.org/cancer/liver-cancer/treating/chemotherapy.html. Accessed on January 26, 2023.
Ammori JB, Kemeny NE, Fong Y, et al. Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution. Ann Surg Oncol. 2013;20(9):2901-2907.
Atli A, Theodore BR, Turk DC, et al. Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up. Pain Med. 2010;11(7):1010-1016.
Borrini L, Bensmail D, Thiebaut JB, et al. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults. Arch Phys Med Rehabil. 2014;95(6):1032-1038.
Centers for Medicare & Medicaid Services (CMS). National Coverage Determination (NCD) for Infusion pumps (280.14).12/17/2004 . [CMS website]. Available at:
http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=223&ncdver=2&CoverageSelection=Both&ArticleType=All&PolicyType=Final&s=Pennsylvania&KeyWord=infusion+pumps&KeyWordLookUp=Title&KeyWordSearchType=And&bc=gAAAABAAAAAAAA==&. Accessed January 26, 2023.
Cohen AD, Kemeny NE. An update on hepatic arterial infusion chemotherapy for colorectal cancer. The Oncologist. 2003;8:553-566.
Dan B, Motta F, Vles JS, et al. Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity. Eur J Paediatr Neurol. Jan 2010;14(1):19-28
Duarte RV, Raphael JH, Sparkes E, et al. Long-term intrathecal drug administration for chronic nonmalignant pain. J Neurosurg Anesthesiol. 2012;24(1):63-70.
Falco FJ, Patel VB, Hayek SM, et al. Intrathecal infusion systems for long-term management of chronic noncancer pain: an update of assessment of evidence. Pain Physician. 2013;16(2 Suppl):SE185-216.
Farid R. Problem-solving in patients with targeted drug delivery systems. Mo Med. 2017; 114(1): 52–56.
Ghosh D, Mainali G, Khera J, et al. Complications of intrathecal baclofen pumps in children: experience from a tertiary care center. Pediatr Neurosurg. 2013;49:138-144.
Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest. 2006;129(1):174-181.
Hamza M, Doleys D, Wells M, et al. Prospective study of 3-year follow-up of low-dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. Oct 2012;13(10):1304-1313.
Hassenbusch SJ, Portenoy RK, Cousins M, et al. Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery -- report of an expert panel. J Pain Symptom Manage. 2004;27(6):540-63.
Hayek S; Neuromodulation Special Interest Group of the American Society of Regional Anesthesia and Pain Medicine. Intrathecal dosing and medication selection. Available at: https://www.asra.com/docs/default-source/asra-family-documents/sig-documents/neuromodulation/intrathecal_dosing_and_medication_selection_pope_edit.pdf?sfvrsn=3256de42_2. Accessed on January 26, 2023.
Hoebers FJ, Pluim D, Verheij M, et al. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT). Int J Cancer. Aug 15 2006;119(4):750-756.
Jarnagin WR, Schwartz LH, Gultekin DH, et al. Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival. Ann Oncol. 2009;20(9):1589-1595.
Liu C, Cui Q, Guo J, et al. Intra-Arterial Intervention Chemotherapy for Sarcoma and Cancerous Ulcer Via an Implanted Pump. Pathol Oncol Res. January 21, 2014.
Malheiro L, Gomes A, Barbosa P, et al. Infectious complications of intrathecal drug administration systems for spasticity and chronic pain: 145 patients from a tertiary care center. Neuromodulation. Jul 2015;18(5):421-427.
Manchikanti L, Staats PS, Singh V, et al. Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain. Pain Phys. 2003;6(1):3-81.
Margetis K, Korfias S, Boutos N, et al. Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia. Clin Neurol Neurosurg. 2014;123:142-145.
Markman M, Olawaiye AB. Intraperitoneal chemotherapy for treatment of ovarian cancer. 09/27/2021. Up to Date. [UpToDate Web site]. Available at: https://www.uptodate.com/contents/intraperitoneal-chemotherapy-for-treatment-of-ovarian-cancer?search=ntraperitoneal chemotherapy for treatment of ovarian cancer&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 [via subscription only]. Accessed January 26, 2023.
Matharu G, Tucker O, Alderson D. Systematic review of intraperitoneal chemotherapy for gastric cancer. Br J Surg. 2011;98(9):1225-1235.
Mayfield Clinic Brain & Spine. Pain pump (intrathecal drug pump). 12/2018. Available at: https://mayfieldclinic.com/pe-pump.htm. Accessed on January 26, 2023.
McGivern JG. Ziconotide: a review of its pharmacology and use in the treatment of pain. Neuropsychiatr Dis Treat. 2007; 3(1): 69–85.
McIntyre A, Mays R, Mehta S, et al. Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review. J Spinal Cord Med. 2014;37(1):11-18.
Mocellin S, Pasquali S, Nitti D. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2009(3):CD007823.
Morton RE, Gray N, Vloeberghs M. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy. Dev Med Child Neurol. 2011;53(8):736-741.
Motta F, Antonello CE, Stignani C. Intrathecal baclofen and motor function in cerebral palsy. Dev Med Child Neurol. 2011;53(5):443-448.
Motta F, Antonello CE. Analysis of complications in 430 consecutive pediatric patients treated with intrathecal baclofen therapy: 14-year experience. J Neurosurg Pediatr.2014;13(3):301-306.
Myers J, Chan V, Jarvis V, et al. Intraspinal techniques for pain management in cancer patients: a systematic review. Support Care Cancer. 2010;18(2):137-149.
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology: Adult Cancer Pain. V2.2022. [subscription required]. Available at:http://www.nccn.org/professionals/physician_gls/pdf/pain.pdf. Accessed January 26, 2023.
National Institute for Health and Care Excellence (NICE). Spasticity in under 19s: management [CG145]. 11/29/2016. Available at: http://guidance.nice.org.uk/CG145. Accessed January 26, 2023.
National Library of Medicine (NLM) of the National Institutes of Health (NIH). Label: Mitigo – morphine sulfate injection. 06/23/2022. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=728f3d83-9a63-0c1f-e053-2a91aa0ac7db. Accessed on January 26, 2023.
Novitas Solutions, Inc. Local Coverage Determination (LCD): Implantable Infusion Pump (L35112). Original: 10/01/2015. Revised 11/14/2019. Available at: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=35112&ver=59&bc=0. Accessed January 26, 2023.
Novitas Solutions, Inc. Local Coverage Article: Compounded Drugs Used in an Implantable Infusion Pump (A54100). Original: 01/01/2016. Revised: 11/21/2019. Available at: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54100&ver=37&bc=0. Accessed January 26, 2023.
Novitas Solutions, Inc. Local Coverage Article: Implantable Infusion Pump (A56778). Original: 08/08/2019. Revised: 11/14/2019. Available at: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=54100&ver=37&bc=0. Accessed January 26, 2023.
Patel VB, Manchikanti L, Singh V, et al. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician. 2009;12(2):345-360.
Peck D, Diwan S. Programmable versus fixed-rate pumps for intrathecal drug delivery. In: Deer TR, Siwan S, Buvanendran A. Intrathecal drug delivery for pain and spasticity.Volume 2. Philadelphia, PA: Elsevier Saunders; 2012: 84-89.
Pin TW, McCartney L, Lewis J, et al. Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review. Dev Med Child Neurol. Oct 2011;53(10):885-895. PMID 21635230.
Pope JE, Deer TR. Guide to Implantable Devices for Intrathecal Therapy. 09/25/2013. [Practical Pain Management Web site]. Available at: https://www.practicalpainmanagement.com/treatments/interventional/pumps/guide-implantable-devices-intrathecal-therapy. Accessed on January 26, 2023.
PRNewswire. Piramal critical care announces the U.S. launch of Mitigo™. 03/11/2019. Available at: https://www.prnewswire.com/news-releases/piramal-critical-care-announces-the-us-launch-of-mitigo-300809900.html#:~:text=BETHLEHEM, Pennsylvania, March 11, 2019 /PRNewswire/ -- Piramal,and 25 mg/mL concentrations in the U.S. market. Accessed on January 26, 2023.
Smith GW, Bukowski RM, Hewlett JS, et al. Hepatic artery infusion of 5-fluorouracil and mitomycin C in cholangiocarcinoma and gallbladder carcinoma. Cancer. 1984;54(8):1513-1516.
Stokic DS, Yablon SA. Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia. Clin Neurophysiol. 2012;123(11):2200-2204.
US Food and Drug Administration (FDA). Infumorph drug label. [FDA Web site]. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018565s020lbl.pdf. Accessed on January 26, 2023.
US Food and Drug Administration (FDA). Medical Devices. What Is an Infusion Pump? 12/13/2017. Available at:
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/GeneralHospitalDevicesandSupplies/InfusionPumps/ucm202495.htm. Accessed January 26, 2023.
US Food and Drug Administration (FDA). Preservative-free Duramorph (morphine sulfate injection, USP). [FDA Web site]. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018565s020lbl.pdf. Accessed on January 26, 2023.
US Food and Drug Administration (FDA). Prialt drug label (ziconotide intrathecal infusion). [FDA Web site]. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021060s003lbl.pdf. Accessed on January 26, 2023.
US Food and Drug Administration (FDA). FDA alerts doctors, patients about risk of complications when certain implanted pumps are used to deliver pain medications not approved for use with the devices. [FDA Web site]. 11/14/2018. Available at: https://www.fda.gov/news-events/press-announcements/fda-alerts-doctors-patients-about-risk-complications-when-certain-implanted-pumps-are-used-deliver. Accessed on January 26, 2023.
Veizi IE, Hayek SM, Narouze S, et al. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients. Pain Med. 2011;12(10):1481-1489.
Vles GF, Soudant DL, Hoving MA, et al. Long-term follow-up on continuous intrathecal baclofen therapy in non-ambulant children with intractable spastic cerebral palsy. Eur J Paediatr Neurol. Nov 2013;17(6):639-644.
Wilkes D. Programmable intrathecal pumps for the management of chronic pain: Recommendations for improved efficiency. J Pain Res. 2014; 7: 571–577.